Madrigal

Madrigal Pharmaceuticals (MDGL)

Company Description

Madrigal Pharmaceuticals is developing novel, high-quality small-molecule drugs addressing major unmet needs in cardiovascular and metabolic diseases. The Company is targeting treatment of both niche and prevalent indications, including fatty liver disease and non-alcoholic steatohepatitis (NASH), diabetes, dyslipidemia and cardiovascular disease.

COMPANY ADDRESS
200 Barr Harbor Drive, Suite 400
West Conshohocken, PA 19428
United States

COMPANY EMAIL
info@madrigalpharma.com

COMPANY WEBSITE



Get BioInvest's perspective on Madrigal Pharmaceutical's CEO


Latest Company News